2021 Mitsubishi Mirage SE
1.2 L • I3 • 78 hp • FWD • AT
ML32FVFJ1MHF07555
Sales history: 1
Highlights
Condition
Run and drive
Seller
Insurance • GEICO
Key included
Yes
Docs
Good
History
1 record
Drive
1.2 L • I3 • 78 hp • FWD • AT
Odometer
105,240 mi ≈ 169,367 km
Primary damage
Front end
Docs
TX • Salvage
Extra
Auction
VIN
ML32FVFJ1MHF07555
Lot number
93707215
Copart
Sale status
Sold by Buy now
Seller type
Insurance
Seller
GEICO
Location
Dallas South, TX
Description
Fuel type
Gasoline
Body color
Red
Body type
Sedan
Trim
SE
All sales final. Always run reports before bid
Sharing our own experience
Over the years, we’ve learned all the ins and outs of car importing — so you don’t have to.
How it works
A full step-by-step guide that walks you through the entire process — from signing up to receiving your car at your doorstep. Clear & beginner-friendly.
Purchase process
Knowledge base
A structured library of content covering every major topic in car importing — including terms, rules, key concepts, and important real-world nuances.
Import encyclopedia
Watch & learn
Short, practical videos packed with tips from real experience. No fluff, no theory — just what actually helps when importing a car from the US to Poland.
Watch guides
Popular Mitsubishi models
2021 Mitsubishi Mirage SE • 1.2 L • I3 • 78 hp • FWD • Automatic • Copart Lot: 93707215 • VIN: ML32FVFJ1MHF07555
Find out more about this 2021 Mitsubishi Mirage SE, available at the Copart salvage car auction as lot 93707215 in Dallas South, TX. This car has Front end main damage. It is listed with Run and drive start condition code. Odometer shows 105,240 mi. This Red Mitsubishi Mirage Sedan is equipped with Gasoline 1.2 L engine, FWD drivetrain, Automatic transmission. Check the vehicle history report for ML32FVFJ1MHF07555 to access detailed information on accidents, ownership, and title status. Review pricing trends and uncover hidden issues before placing your bid.
We use cookies to improve your experience and analyze site usage, as outlined in our Privacy policy. By closing this message or continuing to browse, you consent to their use.
